A. Eisenmenger syndrome | Includes all systemic-to-pulmonary shunts due to large defects leading to a severe increase in pulmonary vascular resistance (PVR) and reversal of the shunt, which becomes pulmonary-to-systemic or bidirectional. Cyanosis, erythrocytosis, and multiple organ involvement are common. |
B. Pulmonary arterial hypertension associated with systemic-to-pulmonary shunts | Patients with moderate to large defects, in which the increase in PVR is mild to moderate, left-right shunt is still present and there is no cyanosis at rest. |
C. Pulmonary arterial hypertension with small defects | Patients with small (coexistent) defects and a clinical picture very similar to idiopathic PAH. Includes:  • ventricular septal defects <1 cm in diameter  • atrial septal defects <2 cm in diameter |
D. Pulmonary arterial hypertension after corrective cardiac surgery | Congenital heart disease has been corrected but PAH has persisted after surgery, or has developed several months or years after surgery in the absence of a significant residual defect. |
Other types of pulmonary vascular disease in CHD patients | |
 Segmental pulmonary arterial hypertension | Segments of the lung vasculature develop pulmonary vascular disease, while other parts may be normally perfused, hyper or hypoperfused. This is now included in group 5 after Nice 2013 [6] |
 Pulmonary vascular disease in Fontan patients | A rise in PVR may occur in patients with a Fontan-type circulation and low pulmonary blood flow, despite low pulmonary arterial pressures. |